Literature DB >> 15878283

Synthesis of gossypol atropisomers and derivatives and evaluation of their anti-proliferative and anti-oxidant activity.

Kalliopi Dodou1, Rosaleen J Anderson, W John Lough, David A P Small, Michael D Shelley, Paul W Groundwater.   

Abstract

Gossypol 1, gossypolone 2, and a series of bis 3 and half Schiff's bases 4 of gossypol were synthesised and tested for anti-proliferative and anti-oxidant activity. (-)-Gossypol (-)-1 was the most potent inhibitor of the proliferation of the HPV-16 keratinocyte cell line (using an MTT viability assay) with a GI50 of 4.8 microM. The bis Schiff's base of (-)-gossypol with L-tyrosine ethyl ester (-)-3b was the most potent inhibitor of iron/ascorbate dependent lipid peroxidation (using the thiobarbituric acid test), with an IC50 of 11.7 microM, with (-)-gossypol being the next most potent of the series, with an IC50 of 13.1 microM. The results from these initial assays suggest that gossypol, as either a racemic mixture rac-1, or the individual atropisomers (-)-1 or (+)-1, has potential for the treatment of psoriasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15878283     DOI: 10.1016/j.bmc.2005.04.026

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

Review 1.  Atropisomerism in medicinal chemistry: challenges and opportunities.

Authors:  Sean T Toenjes; Jeffrey L Gustafson
Journal:  Future Med Chem       Date:  2018-01-30       Impact factor: 3.808

2.  Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells.

Authors:  Kumudha Balakrishnan; William G Wierda; Michael J Keating; Varsha Gandhi
Journal:  Blood       Date:  2008-06-19       Impact factor: 22.113

3.  The immunosuppressive effect of gossypol in mice is mediated by inhibition of lymphocyte proliferation and by induction of cell apoptosis.

Authors:  Wen-bin Xu; Li-hui Xu; Hong-song Lu; Dong-yun Ou-Yang; Huan-jing Shi; Jing-fang Di; Xian-hui He
Journal:  Acta Pharmacol Sin       Date:  2009-04-13       Impact factor: 6.150

4.  Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins.

Authors:  Lan Lan; Hao Liu; Amber R Smith; Carl Appelman; Jia Yu; Sarah Larsen; Rebecca T Marquez; Xiaoqing Wu; Frank Y Liu; Philip Gao; Ragul Gowthaman; John Karanicolas; Roberto N De Guzman; Steven Rogers; Jeffrey Aubé; Kristi L Neufeld; Liang Xu
Journal:  BMC Cancer       Date:  2018-08-10       Impact factor: 4.430

5.  Cancer-Cell-Specific Drug Delivery by a Tumor-Homing CPP-Gossypol Conjugate Employing a Tracelessly Cleavable Linker.

Authors:  Suman Kumar Maity; Paul Stahl; Astrid Hensel; Shirley Knauer; Christoph Hirschhäuser; Carsten Schmuck
Journal:  Chemistry       Date:  2020-01-30       Impact factor: 5.236

Review 6.  Systematic Review of Gossypol/AT-101 in Cancer Clinical Trials.

Authors:  Olga Renner; Mascha Mayer; Christian Leischner; Markus Burkard; Alexander Berger; Ulrich M Lauer; Sascha Venturelli; Stephan C Bischoff
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.